These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28610991)

  • 1. Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model.
    Marostica LL; de Barros ALB; Oliveira J; Salgado BS; Cassali GD; Leite EA; Cardoso VN; Lang KL; Caro MSB; Durán FJ; Schenkel EP; de Oliveira MC; Simões CMO
    Toxicol Appl Pharmacol; 2017 Aug; 329():272-281. PubMed ID: 28610991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549.
    Marostica LL; Silva IT; Kratz JM; Persich L; Geller FC; Lang KL; Caro MS; Durán FJ; Schenkel EP; Simões CM
    Chem Res Toxicol; 2015 Oct; 28(10):1949-60. PubMed ID: 26372186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.
    Silva IT; Carvalho A; Lang KL; Dudek SE; Masemann D; Durán FJ; Caro MS; Rapp UR; Wixler V; Schenkel EP; Simões CM; Ludwig S
    PLoS One; 2015; 10(2):e0117794. PubMed ID: 25674792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
    Chen S; Zhang Z; Zhang J
    Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
    Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
    Lu Z; Wientjes TS; Au JL
    Pharm Res; 2005 Jul; 22(7):1069-78. PubMed ID: 16028007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel.
    Wang B; Hu W; Yan H; Chen G; Zhang Y; Mao J; Wang L
    Biomed Pharmacother; 2021 Apr; 136():111249. PubMed ID: 33450493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets.
    Kausar H; Munagala R; Bansal SS; Aqil F; Vadhanam MV; Gupta RC
    Cancer Lett; 2013 May; 332(1):35-45. PubMed ID: 23340170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].
    Shen HC; Wang XW; Liu YG
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2498-503. PubMed ID: 19080633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.
    Shen R; Li J; Ye D; Wang Q; Fei J
    Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):894-901. PubMed ID: 27590062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
    Li F; Zhu T; Cao B; Wang J; Liang L
    Eur J Cancer; 2017 Oct; 84():184-192. PubMed ID: 28822888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
    Xie CY; Xu YP; Jin W; Lou LG
    Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication and in vivo evaluation of ligand appended paclitaxel and artemether loaded lipid nanoparticulate systems for the treatment of NSCLC: A nanoparticle assisted combination oncotherapy.
    Khatri H; Chokshi N; Rawal S; Patel BM; Badanthadka M; Patel MM
    Int J Pharm; 2020 Jun; 583():119386. PubMed ID: 32376440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Hung LVM; Moon JY; Ryu JY; Cho SK
    Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
    Shen H; Hu D; Du J; Wang X; Liu Y; Wang Y; Wei JM; Ma D; Wang P; Li L
    Eur J Pharmacol; 2008 Dec; 601(1-3):23-9. PubMed ID: 18983839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis.
    Yuan R; Zhao W; Wang QQ; He J; Han S; Gao H; Feng Y; Yang S
    Pharmacol Res; 2021 Aug; 170():105748. PubMed ID: 34217831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of Bevacizumab Maintenance Following Combination Chemotherapy in Human Non-small Cell Lung Cancer Xenograft Models.
    Ishikura N; Yanagisawa M; Noguchi-Sasaki M; Iwai T; Yorozu K; Kurasawa M; Sugimoto M; Yamamoto K
    Anticancer Res; 2017 Feb; 37(2):623-629. PubMed ID: 28179309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic and attenuated effect of HSS in combination treatment with docetaxel plus cisplatin in human non-small-cell lung SPC-A-1 tumor xenograft.
    Jia Y; Zhou D; Jia Q; Ying Y; Chen S
    Biomed Pharmacother; 2016 Apr; 79():27-34. PubMed ID: 27044809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.